If you have nerve pain in your feet, there is a good chance the first prescription you were handed was gabapentin. It is the most widely used medicine for neuropathic pain, it is cheap, and for some people it is the difference between sleeping and not sleeping. It is also, by the numbers, a modest drug: in the best available analysis of trials in diabetic nerve pain, compared with 21 percent on placebo. That gap is real, and it means most people do not get the relief they hoped for. This guide explains what gabapentin does and does not do for neuropathy, how to tell whether it is working, the fixable reasons it often falls short, what doctors try next, and the research testing new non opioid options for people who are still in pain.
Nerve pain still there despite your medicine?
This study is testing a new non opioid option for diabetic nerve pain, for people whose current treatment does not control it well enough.
What gabapentin does for neuropathy
Gabapentin calms overactive nerve signaling. It was developed as a seizure medicine and is FDA approved for nerve pain after shingles, called postherpetic neuralgia. For diabetic peripheral neuropathy it is prescribed off label, which is common and supported by guidelines: the American Diabetes Association lists gabapentinoids, meaning gabapentin and its cousin pregabalin (Lyrica), among the first choices for painful diabetic neuropathy, alongside the antidepressants duloxetine and amitriptyline and sodium channel blockers. Pregabalin, unlike gabapentin, is FDA approved specifically for diabetic nerve pain. Both work the same way, and both need to be started low and increased gradually over weeks.
How much it really helps
The clearest evidence comes from a 2017 Cochrane review that pooled trials of gabapentin at the usual treatment doses. In painful diabetic neuropathy, 38 percent of people had substantial relief, defined as pain cut by at least half, compared with 21 percent on placebo, and 52 percent had moderate relief (pain cut by at least a third) compared with 37 percent on placebo. Put plainly, about one person in six benefits beyond what a placebo would give. For other types of nerve pain, such as sciatica, HIV neuropathy, or cancer-related nerve pain, the evidence is very limited and does not show a clear benefit. So gabapentin is a reasonable first try for diabetic nerve pain, and it is also a drug that leaves most people wanting more.
Side effects are the other half of the story. Dizziness and drowsiness are the most common, followed by swelling in the legs, weight gain, and trouble concentrating, and they are the usual reason people stop before reaching a dose that might have worked.
How to tell whether gabapentin is working
Give it a fair test before judging. That means a dose your doctor considers adequate, taken every day as prescribed for several weeks, since the drug builds up gradually and the dose is usually increased in steps. The question then is not "is the pain gone," because it rarely is, but "is the pain at least a third better, and is sleep better." A pain diary over two weeks, rating pain at night and in the morning, gives a much clearer answer than memory. If the answer is no after a fair trial, or if side effects outweigh the benefit, gabapentin is not working well enough for you, and that is a normal finding rather than a failure.
Why gabapentin may be falling short
The dose was never raised. A 2026 analysis of US prescribing found that most people starting gabapentin, pregabalin, or duloxetine for diabetic nerve pain received doses below those used in trials and never had them increased. If you are still on your starting dose, asking whether it can go higher is the single most useful question to bring to your next visit.
Missed doses. Gabapentin is taken two or three times a day, and skipped doses blunt the effect.
The cause is not what it seemed. Vitamin B12 deficiency, which is more common in people taking metformin, thyroid problems, heavy alcohol use, and some medicines also damage nerves, and treating them can change the picture.
Blood sugar. Nerve pain tends to be worse when glucose runs high, and better long term control reduces the risk of neuropathy getting worse; see our type 2 diabetes page.
It is simply not your drug. Response to nerve pain medicines is individual, which is why guidelines list several first choices rather than one.
What doctors usually try next
Guidelines give a clear sequence. If gabapentin has not helped at an adequate dose, the next step is usually to switch to a medicine from a different class, most often duloxetine (an SNRI) or a tricyclic antidepressant such as amitriptyline, or to try pregabalin, which some people tolerate better even though it works similarly. If one medicine helps partly, combining two from different classes, such as a gabapentinoid with duloxetine, can add relief. For pain concentrated in the feet, a high strength capsaicin patch applied in a clinic is FDA approved, and for people who have not responded to medicines, diabetes guidance recognizes spinal cord stimulation as an option. What guidelines do not recommend as first- or second-line treatment is opioids, including tramadol and tapentadol, because long-term benefit is unproven and the risks are significant. Never stop gabapentin suddenly: it should be tapered under medical supervision to avoid withdrawal symptoms.
Our guide to chronic pain treatment options covers each approach in more detail.
Why new non opioid options are being tested now
Everything above explains why painful diabetic neuropathy is one of the busiest areas of pain research: the standard medicines help only partly, they cause side effects that make people stop, and the alternative that doctors are told to avoid is opioids. New non opioid medicines that act on pain signals in different ways are being tested in people who know this problem firsthand, those with type 1 or type 2 diabetes who have had burning or shooting pain in both feet or legs for many months and are not taking opioids for it. If you have given gabapentin or Lyrica a fair trial and your pain is still there, you are exactly who those studies are designed for. Studies like these are placebo controlled; our guide explains how that works. If your nerve pain has another cause, such as shingles or a back problem, these particular studies will not fit, but your doctor can still work through the alternatives above with you.
How to find a diabetic nerve pain study
AllClinicalTrials.com lists neuropathy studies recruiting across the US, and you can filter by location before applying. Right now that includes a study of an investigational non opioid pain medicine for adults with painful diabetic neuropathy in both legs, for people 18 to 80 with type 1 or type 2 diabetes whose foot or leg pain has lasted about 9 months or more and who have not used opioids for chronic pain in the past 3 months. The application takes about 5 minutes: you answer questions about your diabetes, your pain, and the medicines you have tried, and if the study near you looks like a match, the research team contacts you. Nothing is decided until you have gone through informed consent, and participation is voluntary at every step.
Three things to have ready: when your foot or leg pain began, which nerve pain medicines you have tried and at what point you stopped or stayed, and whether you have taken any opioid pain medicine in the past 3 months.
Common questions
Does gabapentin work for neuropathy? For diabetic nerve pain, yes for some people: in pooled trials, 38 percent had substantial relief versus 21 percent on placebo. For many other types of nerve pain, the evidence is too limited to show a clear benefit. It is a reasonable first try, not a guaranteed fix.
How long does gabapentin take to work for nerve pain? Some effect can appear within days, but a fair trial means several weeks at a dose your doctor considers adequate, because the dose is usually increased in steps. Judge it on whether pain and sleep are meaningfully better, not on whether the pain is gone.
Why is gabapentin not working for my nerve pain? The most common reasons are a dose that was never raised, missed doses, another cause of nerve damage such as low vitamin B12, poorly controlled blood sugar, or simply that it is not the right medicine for you. Each of these has a next step.
Can I join a nerve pain study while taking gabapentin? Often yes. Many studies of new pain medicines allow you to continue a stable dose of your current medicine; the listing states its rules. The study above is for people with diabetic neuropathy who are not taking opioids.
Do nerve pain trial participants get paid? Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
See neuropathy clinical trials recruiting now
Browse open studies, filter by location, and apply in about 5 minutes: Neuropathy Clinical Trials.